As of the latest SEC filings, Enliven Therapeutics, Inc. (ELVN) is held by 190 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $63,361,390.40 in market value, representing a significant portion of its portfolio.
Funds holding Enliven Therapeutics, Inc. (ELVN)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ELVN
- CIK:
- 0001672619
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $63,361,390.40 | 1,616,362 | Mar 31, 2026 | May 28, 2026 |
|
FIDGX
Fidelity Small Cap Growth Fund
|
MF | Fidelity | 0.52% | $44,233,770.42 | 1,072,854 | Apr 30, 2026 | Jun 26, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.61% | $38,003,200.00 | 1,280,000 | Feb 28, 2026 | Apr 24, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.05% | $37,876,647.20 | 966,241 | Mar 31, 2026 | May 28, 2026 |
|
FCDTX
Fidelity Stock Selector Small Cap Fund
|
MF | Fidelity | 0.39% | $26,926,941.93 | 653,091 | Apr 30, 2026 | Jun 26, 2026 |
|
FACTX
Fidelity Advisor Health Care Fund
|
MF | Fidelity | 0.83% | $23,913,400.00 | 580,000 | Apr 30, 2026 | Jun 26, 2026 |
|
FOCSX
Fidelity Small Cap Growth K6 Fund
|
MF | Fidelity | 0.55% | $23,493,018.92 | 569,804 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.02% | $19,497,452.80 | 497,384 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.05% | $16,055,209.38 | 389,406 | Apr 30, 2026 | Jun 26, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 0.71% | $13,558,980.26 | 328,862 | Apr 30, 2026 | Jun 26, 2026 |
|
QUAZX
AB Small Cap Growth Portfolio
|
MF | Independent / Boutique | 0.45% | $13,077,620.01 | 317,187 | Apr 30, 2026 | Jun 24, 2026 |
|
FSOPX
Fidelity Series Small Cap Opportunities Fund
|
MF | Fidelity | 0.26% | $13,050,366.98 | 316,526 | Apr 30, 2026 | Jun 26, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.16% | $12,644,195.20 | 322,556 | Mar 31, 2026 | May 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.10% | $12,531,730.40 | 319,687 | Mar 31, 2026 | May 28, 2026 |
|
FIDGX
Fidelity Small Cap Growth Fund
|
MF | Fidelity | 0.13% | $11,004,575.61 | 266,907 | Apr 30, 2026 | Jun 26, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.20% | $10,785,397.23 | 363,267 | Feb 28, 2026 | Apr 24, 2026 |
|
FSOPX
Fidelity Series Small Cap Opportunities Fund
|
MF | Fidelity | 0.18% | $9,247,889.00 | 224,300 | Apr 30, 2026 | Jun 26, 2026 |
|
-
VIP Health Care Portfolio
|
ETF | Independent / Boutique | 0.85% | $8,545,600.00 | 218,000 | Mar 31, 2026 | May 26, 2026 |
|
XPH
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
|
ETF | State Street (SPDR) | 2.45% | $7,538,042.40 | 192,297 | Mar 31, 2026 | May 28, 2026 |
|
DFSTX
U.S. SMALL CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.04% | $7,410,515.28 | 179,736 | Apr 30, 2026 | Jun 24, 2026 |
|
DFAS
Dimensional U.S. Small Cap ETF
|
ETF | Dimensional Fund Advisors | 0.05% | $7,254,624.65 | 175,955 | Apr 30, 2026 | Jun 29, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.02% | $6,977,209.38 | 235,002 | Feb 28, 2026 | Apr 24, 2026 |
|
FIKNX
Fidelity Small Cap Value Fund
|
MF | Fidelity | 0.13% | $6,834,985.71 | 165,777 | Apr 30, 2026 | Jun 26, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.03% | $6,385,161.09 | 215,061 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.04% | $5,790,470.39 | 195,031 | Feb 28, 2026 | Apr 28, 2026 |
Advertisement (320x50)